Sixty Degree Capital closes $338 million CAD for third venture fund
The new fund looks to invest in enterprise software and healthtech startups.
Stay updated with breaking news from Sixty Degree. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new fund looks to invest in enterprise software and healthtech startups.
If this were The Matrix, you wouldn't want a robot climbing into your head. Now imagine if instead of trying to suck the life out of you, they...
Hello, friends, and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.
Arcellx, a Gaithersburg, Md.-based clinical-stage biopharmaceutical company advancing a pipeline of adaptive and controllable cell therapies, raised $115m in Series C financing. The round was co-led by Samsara BioCapital and CAM Capital, joined by new investors Adage, Asymmetry, CaaS Capital, Cambrian Bio, Sixty Degree, Soleus Capital, Surveyor Capital (a Citadel company), Suvretta, and Terra Magnum Capital Partners, and existing investors NEA, Novo Holdings, SR One, Takeda Ventures, LG Tech, and Clough Capital. The company intends to use the funds to develop CART-ddBCMA, a BCMA-specific CAR...